We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Approves New Drug for Hodgkin Lymphoma

News   Apr 20, 2017 | Original story from National Cancer Institute

 
FDA Approves Pembrolizumab for Hodgkin Lymphoma

Anatomical illustration of lymphoma. Credit: Terese Winslow

 
 
 

RELATED ARTICLES

Sequencing Offers New Hope for Rare Cancers

News

A cancer’s genetic sequence may be the key to matching people with rare cancers to the right anti-cancer treatments, according to a new clinical trial instigated by patients.

READ MORE

Revealed: How Deadly Pneumococcus Suppresses Immune Defenses

News

Scientists have discovered a new and important function of a toxin produced by disease-causing bacteria that could have significant implications for future vaccine design.

READ MORE

The Role of Oligodendrocytes in MS

News

Mapping of a certain group of cells, known as oligodendrocytes, in the central nervous system of a mouse model of multiple sclerosis (MS), shows that they might have a significant role in the development of the disease. The discovery can lead to new therapies targeted at other areas than just the immune system.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE